Researchers say newly identified cholesterol control pathway is completely separate from anything targeted by existing drugs.

The physical AI platform, named AI Experimentalist, translates research goals from natural language into experiments at scale.

This GEN Spotlight on RNA Therapeutics brings you three interlinked sessions that feature outstanding researchers exploring various aspects of RNA biology and therapeutics.

Sangamo Therapeutics, a pioneering gene editing biotech company in the Bay Area, has filed for Chapter 11 bankruptcy protection and agreed to sell some of its programs and platforms to Eli Lilly and ...

Analysis of lung fluid samples indicated the different phenotypes are underpinned by distinct mechanisms and have differential outcomes.

What is collectively needed, both companies maintain, are more efficient, safer, and scalable approaches to cell engineering.

AuraCyt measures cell physics to generate AI-ready digital fingerprints that reveal the multi-dimensional state and behavior of the cell.

Researchers say the discovery is unexpected because prions are usually discussed in the context of misfolding, aggregation, and brain disease—not immunity or antibiotic discovery.

AbbVie has agreed to acquire Apogee Therapeutics for $10.9 billion, in a deal designed to bolster the buyer’s pipeline with an atopic dermatitis (AD) candidate set to advance to Phase III trials ...

The prevalence of autism spectrum disorder (ASD) is roughly one in 36 people, with a male-to-female ratio of 4:1. The disorder is known to be influenced by multiple factors, both genetic (gene ...

Mice that were nursed on TVA-enriched milk responded faster to infections with viruses or common bacteria, even into adulthood.

A second positive Phase III data readout in two months is a major reason why Intellia Therapeutics shares have soared more than 76% over the past six months—including a 29% surge this past week that ...